Intercept Pharmaceuticals, Inc.

MACQUARIE GROUP LTD

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

27,000

Value ($000)

501

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	501	0.0%	27,000	9/30/2023
2023 Q2	10/27/2023	299	0.0%	27,000	6/30/2023
2023 Q1	6/1/2023	9,217	0.0%	686,267	3/31/2023
2022 Q4	2/21/2023	8,313	0.0%	671,995	12/31/2022
2022 Q3	11/14/2022	9,159	0.0%	655,940	9/30/2022
2022 Q2	8/17/2022	8,909	0.0%	645,069	6/30/2022
2022 Q1	5/16/2022	10,098	0.0%	620,671	3/31/2022
2021 Q4	2/11/2022	10,059	0.0%	617,497	12/31/2021
2021 Q3	11/12/2021	9,228	0.0%	621,412	9/30/2021
2021 Q2	8/13/2021	13,504	0.0%	676,210	6/30/2021
2021 Q1	5/14/2021	15,365	0.0%	665,762	3/31/2021
2020 Q4	2/16/2021	17,406	0.0%	704,684	12/31/2020
2020 Q3	11/13/2020	32,296	0.1%	778,959	9/30/2020
2020 Q2	8/11/2020	36,797	0.1%	768,044	6/30/2020
2020 Q1	5/15/2020	45,030	0.1%	715,214	3/31/2020
2019 Q4	3/18/2020	67,588	0.1%	545,414	12/31/2019
2014 Q1	5/15/2014	2,144	0.0%	6,500	3/31/2014